Article
Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma.
European journal of cancer (Oxford, England : 1990) - 1 May 2016
Roesch Alexander, Paschen Annette, Landsberg Jenny, Helfrich Iris, Becker Jürgen C, Schadendorf Dirk
Abstract excerpt
Despite the recent success of MAPK and immune checkpoint inhibitors in advanced melanoma, intrinsic and acquired resistance mechanisms determine the efficacy of these therapeutic approaches. Therapy resistance in melanoma is not solely driven by genetic evolution, but also by epigenetically driven adaptive plasticity. Melanoma cells are shifting between different transcriptional programs, cell cycle states and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
